Aristolochia esperanzae
Aristolochia esperanzae · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Aristolochia esperanzae is a botanical species currently being studied for its significant medicinal potential. Research indicates that the plant possesses potent antimicrobial activities, making it a subject of interest in pharmacological studies. The chemical profile of this species includes important compounds such as dibenzylbutyrolactone and various flavonoids. These bioactive substances demonstrate effectiveness against specific pathogens, including the bacterium Bacillus cereus. Furthermore, the plant's properties are being investigated for their potential therapeutic application in managing conditions like rheumatism.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Aristolochiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Aristolochia esperanzae is a fascinating botanical species widely recognized by its local common name, Papo-de-peru-do-miúdo. This name serves as a cultural link between the plant and the communities that inhabit its natural range. Understanding these linguistic connections helps researchers and enthusiasts alike appreciate the diverse heritage surrounding regional flora. By identifying the plant through both its scientific and vernacular titles, one gains a deeper perspective on its ecological importance. Such relationships highlight the intricate bond between human language and the natural world.
Sources: Catalogue of Life (COL)
Taxonomy
Aristolochia esperanzae is a fascinating botanical specimen that belongs to the vast kingdom Plantae. Within this expansive kingdom, the plant is specifically classified under the class Equisetopsida. It is further organized into the order Piperales, highlighting its unique evolutionary lineage. As a member of the family Aristolochiaceae, it shares characteristics with many other distinctive flowering plants. Finally, it is categorized under the genus Aristolochia, which defines its specific biological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Piperales |
| Family | Aristolochiaceae |
| Genus | Aristolochia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aristolochia esperanzae is a plant species widely distributed across several regions of Southern America. Its presence is notably documented within Brazil, specifically spanning through both the Southeast and West-Central territories. The species also extends into the southern reaches of the continent, finding habitats in Paraguay. In Argentina, it can be found ranging from the Northeast to the Northwest regions. This broad geographic spread highlights the adaptability of the plant within various South American ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Aristolochia esperanzae relies on an obligatory climbing habit to navigate its environment and reach the sunlight necessary for its survival.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Aristolochia esperanzae stands out as a notable species within the genus due to its significant antimicrobial properties. Research indicates that methanolic extracts of this plant demonstrate potent activity against Bacillus cereus, specifically inhibiting the formation and degradation of its biofilms. While these plants are ethnopharmacologically valuable, their medicinal use is often complicated by the presence of toxic aristolochic acids. To address this, studies have explored bioconversion methods using Battus polydamas larvae to detoxify the biomass while preserving its beneficial traits. Ultimately, this process has been shown to decrease the hemolytic activity of A. esperanzae while maintaining its effective antimicrobial potential.
Compounds
Conditions
Aristolochia esperanzae demonstrates significant antimicrobial activity by effectively treating Bacillus cereus. The plant's aqueous extract also shows anti-inflammatory potential through its ability to treat the carrageenan pleurisy test. Research indicates that this species can treat complete adjuvant Freunds (CFA) models in mice. Furthermore, the plant is effective in treating zymosan inflammatory models by inhibiting nitric oxide production and leukocyte migration. These biological properties support the traditional medicinal use of Aristolochia esperanzae to treat rheumatism.